Literature DB >> 3190193

In vitro susceptibilities of Nocardia species to newer antimicrobial agents.

P Berkey1, D Moore, K Rolston.   

Abstract

The in vitro activities of various quinolones, two newer cephalosporins, and imipenem against 23 strains of Nocardia asteroides, 4 strains of Nocardia brasiliensis, and 4 strains of Nocardia caviae were determined by an agar dilution method. PD-117558, a newer carboxyquinolone, and imipenem were the most active agents tested, inhibiting 90% of N. asteroides isolates at an MIC of 2 micrograms/ml. Of the 23 strains of N. asteroides, 15 were susceptible to cefpirome and 10 were susceptible to ciprofloxacin. The N. brasiliensis and N. caviae strains were very susceptible to PD-117558 (MIC, less than or equal to 1 microgram/ml), moderately susceptible to ciprofloxacin, and resistant to most of the other tested drugs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190193      PMCID: PMC172347          DOI: 10.1128/AAC.32.7.1078

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Disseminated Nocardia caviae infection.

Authors:  J C Arroyo; S Nichols; G F Carroll
Journal:  Am J Med       Date:  1977-03       Impact factor: 4.965

2.  Nocardia asteroides infection complicating neoplastic disease.

Authors:  L S Young; D Armstrong; A Blevins; P Lieberman
Journal:  Am J Med       Date:  1971-03       Impact factor: 4.965

3.  Susceptibility of Nocardia asteroides to new quinolones and beta-lactams.

Authors:  M E Gombert; T M Aulicino; L duBouchet; L R Berkowitz
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

4.  In vitro susceptibility of Nocardia asteroides to 25 antimicrobial agents.

Authors:  D H Dewsnup; D N Wright
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

Review 5.  The clinical spectrum of Nocardia brasiliensis infection in the United States.

Authors:  R A Smego; H A Gallis
Journal:  Rev Infect Dis       Date:  1984 Mar-Apr

6.  Nocardial infections in the United States, 1972-1974.

Authors:  B L Beaman; J Burnside; B Edwards; W Causey
Journal:  J Infect Dis       Date:  1976-09       Impact factor: 5.226

7.  Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin.

Authors:  M E Gombert
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

8.  Trimethoprim-sulfamethoxazole therapy for Nocardia infections.

Authors:  R A Smego; M B Moeller; H A Gallis
Journal:  Arch Intern Med       Date:  1983-04

9.  Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams.

Authors:  L Gutmann; F W Goldstein; M D Kitzis; B Hautefort; C Darmon; J F Acar
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

10.  In-vitro activity of newer quinolones against aerobic bacteria.

Authors:  R Auckenthaler; M Michéa-Hamzehpour; J C Pechère
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

  10 in total
  11 in total

1.  Treatment of multiple subcutaneous Nocardia asteroides abscesses with ciprofloxacin and doxycycline.

Authors:  P M Bath; K W Pettingale; J Wade
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

2.  Pulmonary nocardiosis associated with cerebral abscess successfully treated by co-trimoxazole: a case report.

Authors:  Seyyed Saeed Eshraghi; Siamak Heidarzadeh; Abdolreza Soodbakhsh; Mohammadreza Pourmand; Amir Ghasemi; Mohsen GramiShoar; Ensieh Zibafar; Amir Aliramezani
Journal:  Folia Microbiol (Praha)       Date:  2014-01-03       Impact factor: 2.099

3.  Nocardia thyroiditis: unusual location of infection.

Authors:  C Carriere; H Marchandin; J M Andrieu; A Vandome; C Perez
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

4.  In vitro susceptibility of Nocardia spp. to a new fluoroquinolone, tosufloxacin (T-3262).

Authors:  K Yazawa; Y Mikami; J Uno
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

5.  Mediastinitis due to Nocardia asteroides after cardiac transplantation.

Authors:  F Thaler; B Gotainer; G Teodori; C Dubois; P Loirat
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 6.  Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.

Authors:  Barbara A Brown-Elliott; June M Brown; Patricia S Conville; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

7.  In vitro antimicrobial susceptibilities of Nocardia species.

Authors:  N Khardori; R Shawar; R Gupta; B Rosenbaum; K Rolston
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

Review 8.  Review of nocardial infections in France 1987 to 1990.

Authors:  P Boiron; F Provost; G Chevrier; B Dupont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

Review 9.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

Review 10.  Developments in quinolones. Bacteriology, pharmacokinetics and initial clinical experience of several investigational quinolone derivatives.

Authors:  R Janknegt; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1989-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.